secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tarsus Pharmaceuticals, Inc. (TARS)
CIK:        0001819790
Form:       8-K
Filed at:   2024-12-19T23:59:59+00:00
Accession:  0001819790-24-000138
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Tarsus Pharmaceuticals signs 10-year lease for new HQ in Irvine, CA
-------------------------------------------------------------------

- Lease for 59,626 sq. ft. at 17700 Laguna Canyon Road, Irvine, CA; term 120 months.
- Initial monthly base rent $211,672.30, with ~3% annual increases; 5-month rent abatement (~$656,756).
- Construction allowance up to ~$6 million; security deposit via $2.56M letter of credit.
- Lease commences ~11 months after signing or upon start of business activities at Premises.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819790/000181979024000138/0001819790-24-000138-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819790/000181979024000138/tars-20241216.htm
  HTML page:      https://secwatch.observer/filing/0001819790-24-000138

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer